Kihoon Han
고려대학교 정신건강의학교실 · 생화학·유전·분자생물학
한기훈 교수의 연구실은 신경발달 및 정신질환의 분자 기전을 규명하는 데 초점을 맞추고 있습니다. 특히 SHANK3 유전자 변이가 관련된 자폐 스펙트럼 장애, 조현병, 양극성장애 등 다양한 뇌질환의 분자적 기전과 관련된 전사체 분석 및 신호전달 경로를 연구하고 있습니다. 또한 MeCP2, FMRP 등 핵심 신경조절 단백질의 조절 메커니즘과 그가 영향을 미치는 시냅스 구조 및 기능 이상에 대한 분자 기전을 탐구하고 있습니다.
표시된 성과는 수집된 데이터 기준으로 산출되며, 일부 차이가 있을 수 있습니다.
Proper neurological function in humans requires precise control of levels of the epigenetic regulator methyl CpG-binding protein 2 (MeCP2). MeCP2 protein levels are low in fetal brains, where the predominant MECP2 transcripts have an unusually long 3' untranslated region (UTR). Here, we show that miR-483-5p, an intragenic microRNA of the imprinted IGF2, regulates MeCP2 levels through a human-specific binding site in the MECP2 long 3' UTR. We demonstrate the inverse correlation of miR-483-5p and
Silencing of fragile X mental retardation 1 (FMR1) gene and loss of fragile X mental retardation protein (FMRP) cause fragile X syndrome (FXS), a genetic disorder characterized by intellectual disability and autistic behaviors. FMRP is an mRNA-binding protein regulating neuronal translation of target mRNAs. Abnormalities in actin-rich dendritic spines are major neuronal features in FXS, but the molecular mechanism and identity of FMRP targets mediating this phenotype remain largely unknown. Cyto
Mania causes symptoms of hyperactivity, impulsivity, elevated mood, reduced anxiety and decreased need for sleep, which suggests that the dysfunction of the striatum, a critical component of the brain motor and reward system, can be causally associated with mania. However, detailed molecular pathophysiology underlying the striatal dysfunction in mania remains largely unknown. In this study, we aimed to identify the molecular pathways showing alterations in the striatum of SH3 and multiple ankyri
Variants of the SH3 and multiple ankyrin repeat domain 3 (<i>SHANK3</i>) gene, encoding excitatory postsynaptic core scaffolding proteins, are causally associated with numerous neurodevelopmental and neuropsychiatric disorders, including autism spectrum disorder (ASD), bipolar disorder, intellectual disability, and schizophrenia (SCZ). Although detailed synaptic changes of various <i>Shank3</i> mutant mice have been well characterized, broader downstream molecular changes, including direct and i
Recent molecular genetic studies have identified 100s of risk genes for various neurodevelopmental and neuropsychiatric disorders. As the number of risk genes increases, it is becoming clear that different mutations of a single gene could cause different types of disorders. One of the best examples of such a gene is <i>SHANK3</i>, which encodes a core scaffold protein of the neuronal excitatory post-synapse. Deletions, duplications, and point mutations of <i>SHANK3</i> are associated with autism
BACKGROUND The effect of foot orthoses in terms of kinematics and kinetics during walking could be affected on different geometrical designs. Therefore, the purpose of this study was to compare the biomechanical and clinical effects of 3 different insoles on rearfoot motion (RFM) and ankle joint moment parameters. MATERIAL AND METHODS Twenty eight university students with flexible flatfoot were recruited for this study, and each participant was asked to wear 3 different insoles: normal insole wi
The SH3 and multiple ankyrin repeat domains 3 (Shank3) proteins are core organizers of the postsynaptic density in neuronal excitatory synapses, and their defects cause various neurodevelopmental and neuropsychiatric disorders. Mechanistically, Shank3 directly and indirectly interacts with hundreds of synaptic proteins with diverse functions and potentially exerts its regulatory roles in synaptic development and function via these interactors. However, Shank3-dependent regulation of synaptic abu
Recent molecular genetic studies have suggested that two members of the cytoplasmic FMR1-interacting protein (<i>CYFIP</i>) gene family, <i>CYFIP1</i> and <i>CYFIP2</i>, are causally associated with several brain disorders. However, the clinical features of individuals with <i>CYFIP1</i> and <i>CYFIP2</i> variants are quite different. In addition, null mice for either <i>Cyfip1</i> or <i>Cyfip2</i> are lethal, indicating that these two genes cannot compensate for each other in vivo. Although the
Cytoplasmic FMR1-interacting protein 2 (CYFIP2) is a key component of the WAVE regulatory complex (WRC) which regulates actin polymerization and branching in diverse cellular compartments. Recent whole exome sequencing studies identified <i>de novo</i> hotspot variants in <i>CYFIP2</i> from patients with early-onset epileptic encephalopathy and microcephaly, suggesting that CYFIP2 may have some functions in embryonic brain development. Although perinatal lethality of <i>Cyfip2</i>-null (<i>Cyfip
The cytoplasmic fragile X mental retardation 1 (FMR1)-interacting protein 2 (<i>CYFIP2</i>) gene is associated with epilepsy, intellectual disability (ID), and developmental delay, suggesting its critical role in proper neuronal development and function. CYFIP2 is involved in regulating cellular actin dynamics and also interacts with RNA-binding proteins. However, the adult brain function of CYFIP2 remains unclear because investigations thus far are limited to <i>Cyfip2</i> heterozygous (<i>Cyfi